E. Danila (Vilnius, Lithuania)
The feasibility of a lung cancer screening program in rural Ireland M. V. Roberts, S. Hall, K. McManus, R. P. Convery (Craigavon, Belfast, United Kingdom)
| |
Autofluorescence bronchoscopy in the diagnosis of preneoplastic changes and synchronous bronchial carcinoma A. Debeljak, N. Triller, P. Kecelj, I. Kern (Golnik, Slovenia)
| |
Urgent referrals to respiratory medicine from radiology: an audit N. J. Deans, S. Bradley (Dundee, United Kingdom)
| |
The invasive diagnostics of lung cancer with secondary inflammatory changes I. M. Kuznetsov, O. B. Ilina, G. S. Zubov, S. A. Shalaev, L. N. Bisenkov (St. Petersburg, Russian Federation)
| |
Clinical pathology of bronchioloalveolar carcinoma L. M. Grinberg, R. B. Berdnikov (Ekaterinburg, Russian Federation)
| |
Comparison of liquid-based cytology and conventional cytology: abnormal lesion on bronchoscopy E. Choi, J. W. Son (Daejeon, Republic Of Korea)
| |
Evaluating the role of muc4 expression in the differential diagnosis of mesothelioma and adenocarcinoma of the lung A. Kargi, A. Hayretdag, Z. Aydogdu, D. Gurel, A. Onen, A. Sanli, A. Akkoclu (Izmir, Turkey)
| |
Small cell lung cancer – possibility and difficulties in cytological diagnosis J. J. Domagala-Kulawik, R. Krenke, R. Chazan (Warsaw, Poland)
| |
The value of HMBE-1, calretinin and cytokeratin5/6 for diagnosis of epitheloid malignant mesothelioma J. M. Stojsic, J. K. Radojicic, V. N. Todorovic, N. C. Drndarevic (Belgrade, Serbia And Montenegro)
| |
Diagnostic yield of cytology and percutaneous biopsy in pleural malignancy R. Mukherjee, W. Mohamad, J. S. Mann (Wolverhampton, United Kingdom)
| |
Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy E. Artan, M. Kiyik, H. C. Tigin, T. Karadeli, K. Epozturk, N. Urer, H. Ozyurt, S. Cikrikcioglu (Istanbul, Turkey)
| |
CT scanning is an imperfect means of predicting pathological stage in lung cancer R. Dhar, V. Jeebun, H. W. Clague (Sunderland, United Kingdom)
| |
Computer tomographic-guided transthoracic needle aspiration biopsy – 5 years in review B. M. Seabra, A. Furtado, R. Nogueira, I. Bastos, B. Parente (Vila Nova de Gaia, Portugal)
| |
Impact of PET scanning on lung cancer management in a U.K. centre D. A. Stock, A. McIver, K. Mohan, M. J. Ledson, M. J. Walshaw (Liverpool, United Kingdom)
| |
Is bone marrow biopsy needed in staging small cell carcinoma? E. Torun, B. Caglayan, A. Fidan, B. Salepci (Istanbul, Turkey)
| |
Immunohistochemical investigation and prognostic evaluation of micrometastases within the bone morrow and the lymph nodes N. Mutlu, M. Kiyik, H. C. Tigin, L. Kilic, E. Artan, T. Karadeli, K. Epozturk, N. Urer, H. Ozyurt, S. Cikrikcioglu (Istanbul, Turkey)
| |
Influence of verbal and written patient information on tolerance of fiberoptic bronchoscopy in a Tunisian pneumology unit H. Aouina, S. Fnina, S. Bacha, L. Gharbi, M. A. Baccar, S. Azzabi, H. Bouacha (Tunis, Tunisia)
| |
Association of smoking status and bronchoscopic findings in primary lung cancer S. Arinc, M. Ertugrul, C. Salturk, L. Y. Tuncer, E. Sulu, H. B. Takir, A. Yilmaz (Istanbul, Turkey)
| |
Evaluation of lung cancer cases diagnosed by fiberoptic bronchoscopy (Fob) O. Yazicioglu Mocin, M. Coban Agca, P. Pazarli, O. Unal Bayraktar, D. Duman, O. Aktas, T. Karagoz (Istanbul, Cankiri, Turkey)
| |
Evaluation of the role of bronchoscopy in the diagnosis of lung cancer M. Rancic, S. Rancic, M. Cekic, L. Ristic, I. Stankovic, T. Pejcic, N. Krstic (Nis, Serbia And Montenegro)
| |
Women lung cancer: factors related to survival E. Sen, S. Erol, A. Kaya, I. Savas, U. Gonullu (Ankara, Turkey)
| |
Prognostic parameters in patients with lung cancer C. S. Tsobanidou, E. A. Boutsikou, D. Anestakis, I. Boukovinas, D. S. Rizos, T. Toliou (Thessaloniki, Greece)
| |
Prognostic factors in small cell carcinoma E. Torun, A. Fidan, B. Caglayan, T. Salepci, B. Salepci (Istanbul, Turkey)
| |
Do cavitating non-small cell lung cancer patients have a more aggressive disease? M. B. Cekic, M. H. Rancic (Nis, Serbia And Montenegro)
| |
Serum carcinoembryonic antigen (CEA) level as a predictive marker for distant metastasis in non-small cell lung cancer A. Ursavas, M. Karadag, I. Ercan, O. Ozkubat, S. Yesilkaya, R. O. Gozu (Bursa, Turkey)
| |
The usefulness of Cyfra 21-1 as a disease marker in malignant pleural mesothelioma (MPM) K. Naoki, H. Kunikane, H. Okamoto, N. Hida, Y. Narita, I. Nakachi, I. Kawada, H. Watanabe, H. Yasuda, K. Soejima, A. Ishizaka, K. Watanabe (Yokohama, Tokyo, Japan)
| |
Attempt of detection of CYFRA 21-1 in exhaled breath condensate by patients with NSCLC S. Tahanovich, C. Gessner, H. Kuhn, H. Wirtz (Leipzig, Germany)
| |
Importance of CYFRA-21 in estimation of survival of patients with NSCLC V. Karlicic, A. Jovelic, I. Tomic (Belgrade, Serbia And Montenegro)
| |
Isoenzyme regan – marker enzymatic – in lung cancer D. Garbulet, A. Tomosoiu (Iasi, Romania)
| |
A serum level of IGF-I, IGF-II and IGFBP-3 in patients with small cell lung cancer (SCLC) during chemotherapy T. Izycki, W. Naumnik, M. Ossolinska, E. Chyczewska (Bialystok, Poland)
| |
The evaluation of bromodeoxyuridine labelling index in lung cancer B. Akpolat, A. Bilir, S. Tanju, S. Ziyade, A. Toker, S. Dilege, G. Kalayci (Istanbul, Turkey)
| |
Molecular markers in non-small cell lung carcinoma B. T. Ilievska Poposka, G. K. Petrusevska, B. Dimova, S. A. Atanasova, S. Z. Talevski, S. Smickova, T. Stefanovski (Skopje, Fyrom)
| |
Impaired oxidant/antioxidant balance and relationships between inflammatory markers and antioxidants in patients with primary lung cancer H. Firat, S. Yardim Akaydin, E. Caliskan, R. Ergun, S. Ardic, B. Simsek (Ankara, Turkey)
| |
Polymorphism of GSTT1 and GSTM1 genes in lung cancer A. I. Dmitrieva, V. V. Novitski, N. V. Sevostyanova (Tomsk, Russian Federation)
| |
Lung resistance-related protein in lung cancer and lung lesions in Hodgkin disease D. A. Bazyka, L. I. Shvayko (Kiev, Ukraine)
| |
Nucleolar organizer regions in lung cancer in plutonium plant workers M. V. Belosokhov (Ozyorsk, Russian Federation)
| |
The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients M. S. Park, W. Y. Chung, S. M. Kang, M. K. Byun, J. H. Jung, S. B. Choi, C. H. Hahn, Y. S. Kim, J. Chang, S. K. Kim, S. K. Kim (Seoul, Goyang, Republic Of Korea)
| |
Operated lung cancer in women: Tunisian experience A. Marghli, B. Smati, H. Ghrairi, S. Aouadi, M. Abid, F. Mezni, H. Djilani, T. Kilani (Ariana, Tunisia)
| |
Lung cancer morbidity in women H. G. Ganchev, D. N. Kalev, Y. M. Yanchev, E. G. Dimitrova, E. V. Derderyan (Varna, Bulgaria)
| |
CA-125 index and non small cell lung cancer: case report A. Tafur, I. Cherrez-Ojeda, R. Mantilla, T. Guerrero, I. Mendoza, O. Arroba, G. Jordan (Guayaquil, Ecuador)
| |